Cadwell Industries

Executive Summary

Cadwell Industries, founded in 1979 and headquartered in Kennewick, Washington, is a privately held medical device company specializing in neurodiagnostic, neuromonitoring, and sleep diagnostic equipment. The company designs and manufactures integrated hardware and software solutions for neurology and neurophysiology, supported by a strong emphasis on customer service, education, and technical support. With over four decades of industry experience, Cadwell has established a reputation for reliability and innovation in the neurodiagnostic space. While the company is not publicly traded and lacks recent funding disclosures, its long-standing presence suggests a stable, niche market position. The neurodiagnostic market is expected to grow steadily due to the rising prevalence of neurological disorders and increasing demand for sleep studies, which positions Cadwell to benefit from secular trends. However, without clear visibility into revenue, pipeline, or competitive advantages, the investment conviction is tempered.

Upcoming Catalysts (preview)

• Q3 2026FDA Clearance for Next-Generation EEG Platform60% success
• Q4 2026Expansion into Sleep Diagnostic Market with New PSG Device50% success
• Q2 2026Strategic Partnership or Distribution Agreement for International Markets40% success